SCHEDULE: Forager Capital Management Discloses 5.5% Passive Stake in Viemed Healthcare

Forager Capital Management, along with its affiliated fund and principals, has disclosed a passive 5.5% beneficial ownership stake in Viemed Healthcare, Inc. through a Schedule 13G filing.

Summary

• Forager Capital Management, LLC, Forager Fund, L.P., Edward Kissel, and Robert MacArthur (collectively, the "Reporting Persons") have filed a Schedule 13G with the SEC.
• The Reporting Persons collectively beneficially own 2,186,472 shares of Viemed Healthcare, Inc. Common Stock, which represents 5.5% of the total outstanding Common Stock.
• This percentage is based on 39,523,787 shares of Common Stock reported outstanding as of April 29, 2025, in Viemed Healthcare's Quarterly Report on Form 10-Q filed on May 7, 2025.
• Forager Fund, L.P. and Forager Capital Management, LLC hold sole voting and dispositive power over the 2,186,472 shares.
• Edward Kissel and Robert MacArthur hold shared voting and dispositive power over the same 2,186,472 shares.
• The filing indicates a passive investment, as the securities were not acquired or held for the purpose of changing or influencing control of the issuer, other than activities solely in connection with a nomination under Rule 240.14a-11.

Sentiment

Score: 5

Explanation: Neutral, as this is a factual disclosure of a passive ownership stake without explicit positive or negative implications for the company's operations or financial performance.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Disclosure of a significant institutional ownership stake provides transparency regarding the company's shareholder base and may signal confidence from a professional money manager.

Key Dates

Keywords

Viemed Healthcare, Forager Capital Management, Forager Fund, Edward Kissel, Robert MacArthur, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Institutional Investor, Passive Investment